Kindstar Globalgene Technology 배당금
배당금 기준 확인 0/6
Kindstar Globalgene Technology is a dividend paying company with a current yield of 2.42%.
주요 정보
2.4%
배당 수익률
2.8%
환매 수익률
| 총 주주 수익률 | 5.2% |
| 미래 배당 수익률 | 2.4% |
| 배당금 성장 | n/a |
| 다음 배당금 지급일 | n/a |
| 전 배당일 | n/a |
| 주당 배당금 | HK$0.0284 |
| 지급 비율 | 268% |
최근 배당금 업데이트
Recent updates
Kindstar Globalgene Technology's (HKG:9960) Shareholders Have More To Worry About Than Only Soft Earnings
Oct 04
Kindstar Globalgene Technology, Inc.'s (HKG:9960) Shares Leap 29% Yet They're Still Not Telling The Full Story
Oct 03We Think That There Are More Issues For Kindstar Globalgene Technology (HKG:9960) Than Just Sluggish Earnings
Apr 03Kindstar Globalgene Technology (HKG:9960) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Aug 22Analysts Just Made A Notable Upgrade To Their Kindstar Globalgene Technology, Inc. (HKG:9960) Forecasts
Aug 18We're Not Very Worried About Kindstar Globalgene Technology's (HKG:9960) Cash Burn Rate
Jul 07Kindstar Global (Beijing) Technology, Inc. (HKG:9960) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 28결제의 안정성과 성장
배당금 데이터 가져오기
안정적인 배당: Too early to tell whether 9960's dividend payments have been stable as they only just started paying a dividend.
배당금 증가: Too early to tell if 9960's dividend payments are increasing as they only just started paying a dividend.
시장 대비 배당 수익률
| Kindstar Globalgene Technology 시장 대비 배당 수익률 |
|---|
| 세그먼트 | 배당 수익률 |
|---|---|
| 회사 (9960) | 2.4% |
| 시장 하위 25% (HK) | 3.2% |
| 시장 상위 25% (HK) | 7.9% |
| 업계 평균 (Healthcare) | 4.1% |
| 애널리스트 예측 (9960) (최대 3년) | 2.4% |
주목할만한 배당금: 9960's dividend (2.42%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.25%).
고배당: 9960's dividend (2.42%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.92%).
주주에 대한 수익 배당금
수익 보장: With its high payout ratio (267.9%), 9960's dividend payments are not well covered by earnings.
주주에 대한 현금 배당금
현금 흐름 범위: 9960 is paying a dividend but the company has no free cash flows.